Search

Your search keyword '"Ader, Florence"' showing total 385 results

Search Constraints

Start Over You searched for: Author "Ader, Florence" Remove constraint Author: "Ader, Florence" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Language english Remove constraint Language: english
385 results on '"Ader, Florence"'

Search Results

1. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

2. Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study

4. Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France

5. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases

6. Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

7. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study

8. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

11. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

12. Co-infection with Legionella and SARS-CoV-2, France, March 2020

13. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

14. Health crisis: What opportunities for clinical drug research?

15. Acyclovir treatment of varicella-zoster virus meningeal infections and acute kidney injury: a multicentre case series study.

17. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

20. A retrospective comparison of COVID-19 and seasonal influenza mortality and outcomes in the ICUs of a French university hospital

21. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study

22. Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

24. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

27. Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients.

28. New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.

29. Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.

30. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.

32. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

33. Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018

35. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia

37. Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

38. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial

41. Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants

43. Smoking‐associated morbidities on computed tomography lung cancer screens in HIV‐infected smokers

45. Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in France

46. Disappearance of FDG uptake on PET scan after antimicrobial therapy could help for the diagnosis of Coxiella burnetii spondylodiscitis

47. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

48. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.

49. Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis.

50. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

Catalog

Books, media, physical & digital resources